Exciting News for CAR T Cell Therapy to Heavily Treated Patients with Multiple Myeloma
This EHA23 update focuses on recent studies exploring CAR T cell therapy for patients with heavily treated multiple myeloma. Sagar Lonial, one of the leading specialists in the world, provides the update with reference to studies from both ASCO23 and EHA23, including CARTITUDE-1 and 4.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
